| BloodRanger vs Hwoarang | 6–10 | 37.50% |
| BloodRanger vs Jin | 4–12 | 25.00% |
| BloodRanger vs Reina | 7–9 | 43.75% |
| BloodRanger vs Steve | 6–6 | 50.00% |
| BloodRanger vs Law | 7–4 | 63.64% |
| BloodRanger vs Bryan | 5–6 | 45.45% |
| BloodRanger vs Lili | 3–8 | 27.27% |
| BloodRanger vs Dragunov | 3–7 | 30.00% |
| BloodRanger vs Jun | 1–9 | 10.00% |
| BloodRanger vs Anna | 4–3 | 57.14% |
| BloodRanger vs King | 1–5 | 16.67% |
| BloodRanger vs Azucena | 3–3 | 50.00% |
| BloodRanger vs Victor | 2–4 | 33.33% |
| BloodRanger vs Kazuya | 1–4 | 20.00% |
| BloodRanger vs Leroy | 3–2 | 60.00% |
| BloodRanger vs Devil Jin | 2–2 | 50.00% |
| BloodRanger vs Claudio | 0–4 | 0.00% |
| BloodRanger vs Nina | 3–1 | 75.00% |
| BloodRanger vs Kuma | 2–2 | 50.00% |
| BloodRanger vs Heihachi | 2–2 | 50.00% |
| BloodRanger vs Yoshimitsu | 2–1 | 66.67% |
| BloodRanger vs Lee | 2–1 | 66.67% |
| BloodRanger vs Eddy | 1–2 | 33.33% |
| BloodRanger vs Paul | 2–0 | 100.00% |
| BloodRanger vs Jack-8 | 1–1 | 50.00% |
| BloodRanger vs Feng | 0–2 | 0.00% |
| BloodRanger vs Leo | 0–2 | 0.00% |
| BloodRanger vs Alisa | 0–2 | 0.00% |
| BloodRanger vs Panda | 0–2 | 0.00% |
| BloodRanger vs Armor King | 2–0 | 100.00% |
| BloodRanger vs Lars | 0–1 | 0.00% |
| BloodRanger vs Zafina | 1–0 | 100.00% |
| BloodRanger vs Raven | 0–1 | 0.00% |
| BloodRanger vs Clive | 0–1 | 0.00% |
Limitations
This data is often requested to give insight into which characters you have more trouble with than others, but it is not particularly helpful for that. The main issue is that it is heavily skewed by how strong the opponents you play are.
For example, this data suggests my worst matchup is clearly vs Reina, but that's just because most of those games are vs Yagami.
There is a way to account for this being worked on. The central idea is to assign each matchup a rating vs you which adjusts based on the result, much like the regular rating but also based on the rating of each player. With this, it would give a better summary of how well you perform vs each character.
In the meantime, this page is here to present the data as requested.